FIELD: medicine, cardiology.
SUBSTANCE: it is suggested to apply cortisol antagonists in addition to clonidine while manufacturing preparation to treat heart failure. Moreover, one should introduce cortisol antagonist or a product that includes cortisol antagonist along with the second medicinal preparation being a combined preparation to be applied either simultaneously, separately or successively. The present innovation provides decreased symptoms of heart failure at decreasing cardiac muscle's fibrosis and heart sizes due to preferable impact upon glucocorticoid receptors in patient's heart and/or kidneys.
EFFECT: higher efficiency of application.
12 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR LEFT VENTRICLE DIASTOLIC FUNCTION IMPROVEMENT | 2012 |
|
RU2627842C2 |
| METHOD OF TREATING PATIENTS WITH RADIATION EXUDATIVE PERICARDITIS | 2009 |
|
RU2415667C1 |
| METHOD FOR TREATING DOGS WITH DILATED CARDIOMYOPATHY COMPLICATED BY CONGESTIVE CARDIAC FAILURE | 2020 |
|
RU2762989C1 |
| METHODS OF TREATING PULMONARY HYPERTENSION | 2012 |
|
RU2599490C2 |
| PREPARATIONS FOR TREATMENT OF METABOLIC SYNDROME COMPRISING HUMAN GROWTH HORMONE IN COMBINATION WITH CORTISOL SYNTHESIS INHIBITOR | 1998 |
|
RU2198679C2 |
| 1,3-DIHYDROIMIDAZOLE-2-THIONE DERIVATIVES FOR USE IN TREATING PULMONARY ARTERIAL HYPERTENSION AND LUNG INJURY | 2013 |
|
RU2718055C2 |
| METHOD FOR ULTRASONIC EARLY DIAGNOSIS OF VENOUS PULMONARY HYPERTENSION FOR PATIENTS WITH CHRONIC HEART FAILURE | 2016 |
|
RU2634633C2 |
| METHOD OF URINARY NORMALISATION IN RENAL MALFUNCTION | 2004 |
|
RU2367442C2 |
| METHODS FOR TREATMENT OF HEART FAILURE AND ISCHEMIC-REPERFUSION INJURY OF HEART | 2017 |
|
RU2767445C2 |
| METHOD FOR TREATING DOGS WITH MITRAL VALVE ENDOCARDIOSIS | 2020 |
|
RU2745653C1 |
